Utilization of catheter‐directed thrombolysis in pulmonary embolism and outcome difference between systemic thrombolysis and catheter‐directed thrombolysis
Interquartile range
Fibrinolytic agent
DOI:
10.1002/ccd.26108
Publication Date:
2015-08-26T14:45:50Z
AUTHORS (20)
ABSTRACT
Objective The aim of the study was to assess utilization catheter‐directed thrombolysis (CDT) and its comparative effectiveness against systemic in acute pulmonary embolism (PE). Background Contemporary real world data regarding outcomes comparing with CDT for PE is sparse. Methods We queried Nationwide Inpatient Sample from 2010 2012 using ICD‐9‐CM diagnosis code 415.11, 415.13, 415.19 PE. used propensity score analysis compare between CDT. Primary outcome in‐hospital mortality. Secondary combined mortality intracranial hemorrhage (ICH). Results Out 110,731 patients hospitalized PE, we identified 1,521 treated thrombolysis, which 1,169 received 352 After propensity‐matched comparison, primary secondary were significantly lower group compared (21.81% vs. 13.36%, OR 0.55, 95% CI 0.36–0.85, P value = 0.007) (22.89% 0.52, 0.34–0.80, 0.003), respectively. median length stay [7 days, interquartile range (IQR) (5–9 days) 7 IQR (5–10 days), 0.17] not significant two groups. had higher cost hospitalization [$17,218, ($12,272–$23,906) $23,799, ($17,892–$35,338), < 0.001]. Multivariate increasing age, saddle cardiopulmonary arrest, Medicaid insurance as independent predictors Conclusions associated ICH. © 2015 Wiley Periodicals, Inc.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (25)
CITATIONS (84)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....